# Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder

> **NCT06067737** · PHASE2 · RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 90 (estimated)

## Conditions studied

- Opioid Use Disorder

## Interventions

- **DRUG:** Psilocybin
- **DRUG:** Psilocybin

## Key facts

- **NCT ID:** NCT06067737
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-08
- **Primary completion:** 2028-07
- **Final completion:** 2029-05
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06067737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06067737, "Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT06067737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*